Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYOV | TLX | AAPG | ||
| Company | Myovant Sciences Ltd | Telix Pharmaceuticals Limited ADR | Ascentage Pharma Group Intl ADR | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 26.99 | 8.05 | 27.00 | ||
| High | 27.00 | 8.14 | 27.68 | ||
| Low | 26.98 | 8.02 | 27.00 | ||
| Latest | 26.98 | 8.03 | 27.68 | ||
| Change | -0.01 | -0.07 | -0.20 | ||
| % Change | -0.04% | -0.86% | -0.72% | ||
| Volume | 2,256,000 | 115,700 | 3,800 | ||
| 20-Day Average Volume | 1,234,240 | 169,800 | 4,120 | ||
| Previous Close | 26.99 | 8.10 | 27.88 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 26.95 | 8.94 | 30.00 | ||
| 20-Day Raw Stochastic | 50.00% | 13.42% | 25.52% | ||
| 20-Day Relative Strength | 61.08 | 35.35 | 40.59 | ||
| Weighted Alpha | +96.20 | -53.06 | +14.58 | ||
| Today's Opinion | 100% Buy | 100% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 96% Buy | 100% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.11% since 03/02/23 | +2.82% since 12/18/25 | -2.91% since 12/17/25 | ||
| Low | 26.95 on 03/06/23 | 7.79 on 12/19/25 | 25.83 on 12/22/25 | ||
| High | 27.00 on 03/09/23 | 8.15 on 12/24/25 | 29.49 on 12/19/25 | ||
| 1-Month | |||||
| %Chg | +0.30% since 02/09/23 | -17.64% since 11/26/25 | -13.82% since 11/26/25 | ||
| Low | 26.90 on 02/13/23 | 7.72 on 12/17/25 | 25.83 on 12/22/25 | ||
| High | 27.06 on 02/13/23 | 10.03 on 12/10/25 | 33.09 on 12/02/25 | ||
| 3-Month | |||||
| %Chg | +0.71% since 12/09/22 | -19.54% since 09/26/25 | -25.85% since 09/26/25 | ||
| Low | 26.75 on 12/16/22 | 7.72 on 12/17/25 | 25.83 on 12/22/25 | ||
| High | 27.06 on 02/13/23 | 11.29 on 10/15/25 | 40.47 on 10/02/25 | ||
| 6-Month | |||||
| %Chg | +36.13% since 09/09/22 | -51.04% since 06/26/25 | -32.17% since 06/26/25 | ||
| Low | 16.26 on 09/23/22 | 7.72 on 12/17/25 | 25.83 on 12/22/25 | ||
| High | 27.06 on 02/13/23 | 16.98 on 07/09/25 | 48.45 on 08/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,623,400 | 2,719,930 | 2,583,375 | ||
| Shares Outstanding, K | 97,235 | 338,721 | 93,330 | ||
| Annual Sales | 230,970,000 | 516,680,000 | 134,350,000 | ||
| Annual Net Income | -205,980,000 | 32,930,000 | -55,540,000 | ||
| Last Quarter Sales | 100,230,000 | N/A | N/A | ||
| Last Quarter Net Income | -57,630,000 | N/A | N/A | ||
| 60-Month Beta | 2.17 | N/A | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 01/26/23 | N/A | N/A | ||
| Latest Earnings Date | 05/09/23 | 01/01/70 | 01/01/70 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||